Author: Shannon Palus

HIV postdoc faked data in published paper, 2 grants

Julia_B
Julia Bitzegeio

An HIV researcher has admitted to faking data in a published paper, a manuscript, and two grant applications, according to a notice released today by the the Office of Research Integrity (ORI).

Former postdoc Julia Bitzegeio faked data in a 2013 paper, published in the Journal of Virology, about how HIV adapts to interferon. In the paper, “the manipulation was really minor,” Theodora Hatziioannou, principal investigator of the lab at the Aaron Diamond AIDS Research Center (ADARC) in New York City where Bitzegeio worked, told Retraction Watch. “She just made cosmetic changes.”

The paper will be corrected, Hatziioannou said. Bitzegeio has left her lab, and her future is somewhat less clear:

Continue reading HIV postdoc faked data in published paper, 2 grants

Two retractions cost economic historian book chapter and journal article

markets and morality

Francisco Gómez Camacho has lost an introduction in The Journal of Markets and Morality of a 2005 issue “for improper use of published material without attribution, as well as a a chapter in a collection of 13 scholarly essays  by Brill Publishers due to “serious citation issues.”

The introduction — to a translation of another scholars’ work, Luis de Molina’s Treatise on Money — is no longer in the online version of The Journal of Markets and Morality. On the cover page, and in the table of contents, of the treatise, references to the introduction are crossed out. Where it once was in the text — page 5 of the PDF of the treatise — is a short retraction notice:

Continue reading Two retractions cost economic historian book chapter and journal article

Gynecologic cancer researcher up to 13 retractions

13277Noriyuki Takai, a gynecologic cancer researcher at Oita University in Japan, has lost another five papers. With a new total of 13, that means he’s now on our leaderboard.

Three of the retractions are from the journal Tumor Biology, one is from the International Journal of Gynecological Cancer, and one from Anticancer Research.

Takai is the first author on all 5 papers.

As has been the case with Takai’s retractions, and there’s evidence that all were felled by issues with figures. In all, according to the retraction notices, “original data were processed inappropriately.” Four end with the following sentence (or some close variation thereof):

Continue reading Gynecologic cancer researcher up to 13 retractions

Hundreds sign letter criticizing Science for reinforcing “damaging stereotypes”

scienceAfter an advice columnist for Science Careers suggested a postdoc “put up with” an adviser’s wandering gaze in June, and an author of a piece in Science partly credited his success to his wife (a Ph.D. scientist) who assumed “the bulk of the domestic responsibilities” in July, some readers have gotten fed up.

These examples are two of four recent instances from Science that reinforce “damaging stereotypes about underrepresented groups in STEM fields,” according to a letter penned by scientists Aradhna K. Tripati, Jennifer B. Glass and Lenny Teytelman. As of this morning, the letter has been signed by more than 300 people; it will be sent to Science/AAAS Editors on Tuesday, July 21.

We showed the letter to Marcia McNutt, the Editor in Chief of Science — set to become the first female leader of the 152-year-old National Academy of Sciences — and she told us:

Continue reading Hundreds sign letter criticizing Science for reinforcing “damaging stereotypes”

Cervical cancer paper is scrapped for duplication in the same journal, year

XLargeThumb.00009577-201507000-00000.CVOver a decade ago, a case report on a woman with cervical cancer and lymphoma was “published twice” by the International Journal of Gynecological Cancer within the span of a few months. The retraction note came out just now.

One copy of the paper appeared in the July 2003 issue of the journal. The second, now-retracted, copy — “Coincidental detection of T-cell rich B cell lymphoma in the para-aortic lymph nodes of a woman undergoing lymph node dissection for cervical cancer: A case report” — was published later that year, in the September issue.

There are just a few cosmetic differences between the headlines and abstracts of the papers  — a “;” instead of a “,”; a change in verb tense, and a typo, for instance. (See a text comparison of the abstracts here.)

The brief retraction note, from the journal’s Editor in Chief Uziel Beller, doesn’t explain what took so long to act on the error — just tosses the blame to whoever was in charge of the journal at the time:

Continue reading Cervical cancer paper is scrapped for duplication in the same journal, year

ASU professor is demoted, will correct book following “unattributed and poorly paraphrased material”

91993Matthew Whitaker at Arizona State University is revising a textbook about modern African-American history after it was found to contain “unattributed and poorly paraphrased material,” according to a statement from the author.

The revised version of the book Peace Be Still: Modern Black America from World War II to Barack Obama will include “a statement of apology and admission of error.”

As a result, Whitaker has been demoted to Associate Professor (from full Professor), costing him $20,000 per year in salary and stipend, according to The Arizona Republic. His previous salary was $163,530.

In addition,

Continue reading ASU professor is demoted, will correct book following “unattributed and poorly paraphrased material”

JCI issues mega-correction for multiple myeloma paper

125-7-coverThe Journal of Clinical Investigation has issued a lengthy correction to a paper about the role of the immune system in the progression and treatment response of multiple myeloma.

The correction changes details from the name of an author to figure legends, and adds entire supplemental figures.

Shortly after the paper’s publication on April 20th, commenters on PubPeer pointed out duplications in multiple figure panels.

Last month, the journal issued an extensive correction note for “Immunosurveillance and therapy of multiple myeloma are CD226 dependent,” which, in part, tries to explain the multiple duplications.

It starts out noting a typo:

Continue reading JCI issues mega-correction for multiple myeloma paper

JAMA issues mega-correction for data breach letter due to “wording and data errors”

s_cover_jcv062315A JAMA letter published in April on data breaches accidentally included some data that shouldn’t have been published, either — specifically, “wording and data errors” that affected five sentences and more than 10 entries in a table. One result — a reported increase in breaches over time — also went from statistically significant to “borderline” significant, according to the first author. (So yeah, this post earns our “mega correction” category.)

According to an author, an “older version” of a table made it into the letter, “Data Breaches of Protected Health Information in the United States,” which was corrected in the journal’s June 23/30 issue.

The letter and table in question detail 949 breaches of “unencrypted protected health information.”  The letter says the number of breaches has increased from 2010 to 2013; the original article claimed that the P value on that increase was <.001, but the correction says it’s really 0.07. The original says 29.1 million personal records were affected in those breaches; the real number is 29.0. And so on.

Continue reading JAMA issues mega-correction for data breach letter due to “wording and data errors”

Cancer Research retraction is fifth for Robert Weinberg; fourth for his former student

13.coverAnother domino has fallen in a chain of retractions for Robert Weinberg, the man who discovered the first tumor-causing gene in humans, along with the first tumor suppressor gene: Cancer Research just retracted a paper of his on some of the molecular steps to metastasis.

The paper, “Concurrent Suppression of Integrin α5, Radixin, and RhoA Phenocopies the Effects of miR-31 on Metastasis,” has been cited 70 times, according to Thomson Scientific’s Web of Knowledge. As we have noted before, Weinberg’s papers are frequently highly cited. His bio at the Whitehead Institute bills him as “a pioneer in cancer research.”

Four of Weinberg’s retracted papers — including this latest — share a first author: Scott Valastyan, once a very promising grad student in Weinberg’s lab. 

This retraction, like Valastyan’s others, is linked to his retracted 2009 Cell paper. (That paper was cited 482 times, and there’s even a video from the Cell press office to go with it). Continue reading Cancer Research retraction is fifth for Robert Weinberg; fourth for his former student

JBC cancer paper felled by duplication is one author’s second retraction this month

25.coverA 2002 paper in the Journal of Biological Chemistry on how lung cancer cells resist death has been retracted for duplicating figures from a 2001 paper.

The retracted paper, “Fibroblast growth factor-2 induces translational regulation of Bcl-XL and Bcl-2 via a MEK-dependent pathway: correlation with resistance to etoposide-induced apoptosis,” shares the first and last authors with the 2001 paper, in Oncogene, as well as two other co-authors.

Here’s JBC’s entire retraction note, a sub-genre with which we’ve become intimately familiar by now:

Continue reading JBC cancer paper felled by duplication is one author’s second retraction this month